Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts

  • kerplunk412
    replied
    My results indicated that most of my PCR products were blunt ended, but it is possible (although unlikely) that occurred during the PNK treatment. There should be no problem with having an extra A on the ends of the reads for alignment and data analysis purposes, and as long as <50% of the products have the A I also don't think it will be a problem for sequencing. That being said, it may be worth it to optimize your PCR with another polymerase, as this should really only involve a gradient PCR or two. Also, lower error rates are never a bad thing.

    Overlapping PCR is also a good option, but may require more optimization than you would think. Overlapping PCR is ideal for high sample numbers, because when processing hundreds of samples it is much less expensive per sample than ligation-based library prep. So if you have a lot of samples it is something you may want to think about.

    Leave a comment:


  • cliffbeall
    replied
    Couldn't you add the Illumina adapter bits by overlapping PCR, as done in 16S amplicon and Nextera protocols?

    Leave a comment:


  • Chr15
    replied
    Thank you for taking the time to respond, much appreciated!

    Using the Taq pol – PNK method to produce our DNA product ready for adaptor ligation, we get only a tiny amount of ligated adaptor product, so it’s reassuring to hear that this method has been problematic for Kerplunk412.

    I think it’s time to move onto the end repair and A-tailing method……..

    ….. which brings me to another question.

    Is it ok to continue using TaqPol to PCR up my DNA ready for adaptor ligation if I switch to the end repair and A-tailing method or should I be using an enzyme which doesn’t leave a 3’ overhang (Pfu) ? The PCR is optimised with TaqPol, but I am concerned that as this already leaves a 3’ A overhang, will the end repair process remove (which I want) this or add a corresponding T on the other strand (which I don’t want).

    Much much appreciated folks!

    C

    Leave a comment:


  • kerplunk412
    replied
    I tried something very similar to this recently, and it worked much worse than I expected. It looked like I had a lot of blunt-ended inserts that made crazy concatemers, which leads me to believe the PNK treatment worked well but the Taq did not add A overhangs as I thought it would. I went ahead and did the end repair and A-tailing and then the ligation worked as expected. I was surprised, but the data was pretty clear.

    Leave a comment:


  • pmiguel
    replied
    Should work.
    You could buy phosphorylated primers and skip the PNK as well.
    --
    Phillip

    Leave a comment:


  • Chr15
    started a topic Is end repair necessary if I use Taq pol and PNK?

    Is end repair necessary if I use Taq pol and PNK?

    Hi,

    We are hoping to carry out NGS of PCR amplified DNA aptamers (80 bp). We have PCR’d up the DNA aptamers using Taq pol (which should generate a 3’ A overhang) and then treated using PNK (to generate a 5’ phosphate). As I understand it the DNA is now in the correct configuration for adaptor ligation (using the Tru Seq PCR free kit), is this correct? The alternative is to end-repair the PCR products and A-tail, but is this necessary if I use the Taq pol – PNK method as above?

    Any advice much appreciated

    C

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...